Home of Hepatology7 rue Daubin1203 GenevaSwitzerland+41 22 807 03 60easloffice@easloffice.eu© 2025 EASL. All rights reserved.Website by Soto.Privacy Policy | Cookie Policy | Terms & Conditions | Cyber Security Explore offerUnlock the full potential of being part of the EASLcommunity. As a member, you’ll gain access toexclusive resources, reduced event fees, top-tierjournals, and professional development opportunitiesdesigned to support your career in hepatologyBecome a memberNurses & Allied Health ProfessionalsLink titleYoung InvestigatorsLink titleBasic ScienceLink titleTitle here Lorem ipsum At the heart of EASL is a diverse and dynamic international community of professionals dedicated to advancing hepatology.Discover how you can get involved and make an impact.Whether you're a member, a Young Investigator, a nurse or allied health professional, or focused on basic science, there's a place for you here. Explore the different pathways to connect, grow and contribute, from membership benefits to tailored programmes and scientific networksLorem ipsum dolor sit ipsum CommunitySign In / Sign UpResourcesWhat We DoAbout Us Partnerships

Kushala Abeysekera

Kush Abeysekera is a consultant hepatologist and senior lecturer in liver disease epidemiology and public health, based between the University of Bristol and Bristol Royal Infirmary.

In 2023 the British Association for the Study of the Liver awarded him the Dame Sheila Sherlock prize for his PhD at the University of Bristol, exploring the prevalence and determinants of steatotic liver disease in young adults. Following this he was selected as an EASL-AASLD Masterclass Scholar. He currently leads the liver programme for the Children of the 90s birth cohort study, to explore the life course of risk factors for early liver disease development amongst adults. He is Divisional Research Lead for Medicine at Bristol Royal Infirmary and a local principal investigator on multiple clinical trials.  He is exploring the characteristics of patients developing liver disease early and strategies to detect cirrhosis in the community proactively. His focus is on what is economically viable in healthcare to address liver health inequalities and how we can reduce barriers t engagement for patients accessing hepatology services.

Scroll to Top

Search EASL